Translation of "Pseudomonas species" in German

Enterococci, Pseudomonas aeruginosa, and other Pseudomonas and Acinetobacter species are resistant to this product.

The reaction is suitably performed by microorganisms of the species Pseudomonas putida utilizing toluene, xylene or cymene.

In contrast, the Pseudomonas species lipase was quantitatively inactivated by all synthesized organophosphonates (FIG.

For one strain each of Pseudomonas species und Acinetobacter baumannii, lower MIC values were established.

Pseudomonas include the species Pseudomonas aeruginosa, which causes disease in people with a weakened immune system.

Bacteria of the Pseudomonas aeruginosa species are hospital germs and are resistant to many common antibiotics.

There may be a particular risk of selecting for ciprofloxacin-resistant bacteria during extended durations of treatment and when treating nosocomial infections and/ or infections caused by Staphylococcus and Pseudomonas species.

There may be a particular risk of selecting for ciprofloxacin-resistant bacteria during extended durations of treatment and when treating nosocomial infections and/or infections caused by Staphylococcus and Pseudomonas species.

Most identified cystoviruses infect Pseudomonas species, but this is likely biased due to the method of screening and enrichment.

The results of the "Oxi/Ferm Tube" assay and of the "API 20 E" assay would permit the strains of Table 1 to be classified as Pseudomonas species, Pseudomonas-like species, Alcaligenes faecalis or Achromobacter species.

This strain of Pseudomonas species DSM 2874 is gram negative and aerobic, and its dry cell mass has a beige coloration.

As Achromobacter species and Alcaligenes faecalis to all intents and purposes do not differ biochemically from Pseudomonas species and the transitions between the genera are gradual, the designation "Pseudomonas" will be chosen for all microorganisms of this invention on account of the characteristic feature of the polar to subpolar flagellation.

Whereas the first-mentioned plasmid provides an especially high synthesis capacity in microorganisms of the species Escherichia coli, the second-mentioned plasmid possesses the advantage that not only in the species Escherichia coli but also in the species Pseudomonas putida, it gives a high expression of the desired enzyme.

The active substances of the formula I and the compositions prepared therefrom are particularly effective against bacteria of the order Pseudomonadales, thus, for example, against bacteria of the family of Pseudomonadaceae, such as Pseudomonas and Xanthomonas species (Pseudomonas tomato, Pseudomonas tabaci, Pseudomonas morsprunorum, Pseudomonas phaseolicola, Pseudomonas lachrymans, Xanthomonas campestris, Xanthomonas oryzae and Xanthomonas vesicatoria).

The process according to claim 1, wherein the Pseudomonas species DSM 2874 is cultured under aerobic conditions in a nutrient solution which contains one assimilable carbon source and is limited in its nitrogen content and wherein the rhamnolipids are subsequently isolated from the culture.

The active ingredients also have an advantageous bactericidal action on, for instance, Staphylococcus aureus, Escheria coli, and Xanthomonas and Pseudomonas species.

We claim: A process for the microbiological production of rhamnolipids comprising the following steps: culturing the microorganism Pseudomonas species DSM 2874 under aerobic conditions in an aqueous nutrient solution containing at least one assimilable carbon source at a pH value of 6.5 to 7.3 and a temperature of 30° to 37° C., then either

The lipase suitable for use as the secondary enzyme or as a secondary enzyme component in the process according to the invention may be obtained from Humicola lanuginosa, as described for example in European patent applications EP 258 068, EP 305 216 and EP 341 947, from Bacillus species, as described for example in International patent application WO 91/16422 or in European patent application EP 384 717, from Pseudomonas species, as described for example in European patent applications EP 468 102, EP 385 401, EP 375 102, EP 334 462, EP 331 376, EP 330 641, EP 214 761, EP 218 272 or EP 204 284 or in International patent application WO 90/10695, from Fusarium species as described, for example, in European patent application EP 130 064, from Rhizopus species as described, for example, in European patent application EP 117 553, or from Aspergillus species as described, for example, in European patent application EP 167 309.

Suitable host cells for the expression of a plasmid according to the invention include strains of the species E. coli or of a related Enterobacterium such as a strain of one of the species Pseudomonas, Salmonella, Enterobacter, Klebsiella or Serratia.

In the figure, this fact is represented in that there is no assignment between the p species (pseudomonas) and the m species (micrococci).

These are a Pseudomonas species resis­tant to mercury, which convert ionic mercury into the atomic, metallic form.

Two types of that enzyme are described so far: StyA/StyB (designated E1), first described from Pseudomonas species, and StyA1/StyA2B (designated E2), first described from Actinobacteria.

According to German Laid-Open Application DOS No. 2,631,048, racemic mixtures of hydantoins can be converted to optically active aminoacids with the aid of micro-organisms of the species Pseudomonas.

Admittedly, micro-organisms are known, for example Pseudomonas species, which, with induction by creatine, are able to produce creatinamidinohydrolase in an amount making working up worthwhile but the achievable yields and the costs of the isolation of the enzyme still represent a limiting factor for the industrial use of the enzyme.